U.S. Life Science Real Estate:
Operator Opportunity Report

The life science market has reset.

Vacancy is elevated. Capital is selective. Manufacturing investment is accelerating. AI biotech is changing space requirements. Federal policy is introducing new risk variables.

If you operate life science real estate, the next five years will require sharper decisions than the last five did.

This report gives you a clear, data-backed view of what is happening, and what to do about it.

When you download the report, you’ll gain:

• The five macro forces reshaping U.S. life science real estate
• Seven near-term leasing and tenant behavior trends
• How AI biotech is changing infrastructure requirements
• Where capital is actually flowing — and why it matters
• The manufacturing shift and its impact on asset performance
• A practical 0–5 year operator action plan

Access the full U.S. Life Science Real Estate: Operator Opportunity report and prepare your portfolio for what comes next.